Postbiotic pA1c®HI for Preventing Insulin Resistance and Obesity in a Caenorhabditis elegans Model of Prediabetes
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26168094 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Deyan Yavorov-Dayliev und 5 weiteren Autor:innen. Beteiligte Einrichtung: Genbioma Aplicaciones S.L., Cein Centro Europeo, Office D3, Pl. Cein, 1-5, Pol. Ind. Mocholí, 31110 Noáin, Navarra, Spain. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Obesity, Insulin Resistance, Probiotics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gobierno de Navarra, Government of Navarra.
Abstract (Originalsprache)
Cardiometabolic diseases such as obesity, prediabetes (PreD), and type 2 diabetes (T2D) are global health challenges linked to metabolic dysfunction. While probiotics show promise, postbiotics offer advantages in stability, safety, and food incorporation. This study evaluates the postbiotic pA1c®HI, a heat-inactivated form of the probiotic pA1c®, for its potential in modulating glucose and lipid metabolism in Caenorhabditis elegans, compared to its live form. Worms were supplemented with pA1c®HI and live pA1c® in glucose-enriched media. Fat accumulation, gene expression, oxidative stress, and lifespan were measured using Nile Red and DHE staining, qPCR, and longevity assays. pA1c®HI significantly reduced glucose-induced fat accumulation, achieving fat reduction comparable to the anti-obesity drug orlistat and showing superior efficacy compared to the live probiotic form. It modulated the expression of genes associated with lipid oxidation (acox-1, cpt-2), fatty acid synthesis (fat-5), insulin signaling (daf-2, daf-16), and oxidative stress response (skn-1). Synergistic combinations with chromium picolinate (PC) and zinc (Zn) further enhanced metabolic outcomes. Importantly, pA1c®HI retained efficacy after thermal treatment (121–135 °C), supporting its potential for use in processed foods. pA1c®HI is a stable, effective postbiotic that modulates key pathways associated with obesity, PreD, and T2D in C. elegans, with superior performance to the live probiotic and added benefits when combined with PC and Zn.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genbioma Aplicaciones S.L., Cein Centro Europeo, Office D3, Pl. Cein, 1-5, Pol. Ind. Mocholí, 31110 Noáin, Navarra, Spain.
- Biochemistry Area, Health Science Department, Faculty of Health Sciences, Public University of Navarra, 31008 Pamplona, Navarra, Spain.
ORCID-Profile: Deyan Yavorov-Dayliev, Miriam Araña, Miguel Barajas
Förderung
- Gobierno de Navarra
- Government of Navarra
Zitieren
APA
Yavorov-Dayliev, D., Iturria, I., Iriarte, L., Araña, M., Barajas, M., & Ayo, J. (2025). Postbiotic pA1c®HI for Preventing Insulin Resistance and Obesity in a Caenorhabditis elegans Model of Prediabetes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26168094
Vancouver
Yavorov-Dayliev D, Iturria I, Iriarte L, Araña M, Barajas M, Ayo J. Postbiotic pA1c®HI for Preventing Insulin Resistance and Obesity in a Caenorhabditis elegans Model of Prediabetes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26168094
BibTeX
@article{YavorovDayliev2025,
author = {Yavorov-Dayliev, Deyan and Iturria, Iñaki and Iriarte, Leyre and Araña, Miriam and Barajas, Miguel and Ayo, Josune},
title = {Postbiotic pA1c®HI for Preventing Insulin Resistance and Obesity in a Caenorhabditis elegans Model of Prediabetes},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26168094}
}
EUVIMED